Clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics
- Year invested 2009
- Investment Stage Public/PIPES
- Sectors
- Investment Status Current
- Website viracta.com/
- Company Status Acquired (by Viracta Therapeutics, Inc.) (NASDAQ: VIRX)